Mahmoud Gheblawi
Edmonton, AB, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Immunometabolism perturbations in post-COVID-19 condition: interleukin-6 and monoamine oxidase interactions drive neuropsychiatric syndromes.
Journal: Brain, behavior, and immunity
Published: February 04, 2025
Plasma taurine level is linked to symptom burden and clinical outcomes in post-COVID condition.
Journal: PloS one
Published: January 26, 2024
SARS-CoV-2 infection downregulates myocardial ACE2 and potentiates cardiac inflammation in humans and hamsters.
Journal: American journal of physiology. Heart and circulatory physiology
Published: November 11, 2022
Urinary angiotensin-converting enzyme 2 and metabolomics in COVID-19-mediated kidney injury.
Journal: Clinical kidney journal
Published: July 30, 2022
An advanced endothelial murine HFpEF model: eNOS is critical for angiotensin 1-7 rescue of the diabetic phenotype.
Journal: Journal of molecular and cellular cardiology
Published: March 24, 2022
Dysregulation of ACE (Angiotensin-Converting Enzyme)-2 and Renin-Angiotensin Peptides in SARS-CoV-2 Mediated Mortality and End-Organ Injuries.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: November 30, 2021
Sex- and age-specific regulation of ACE2: Insights into severe COVID-19 susceptibility.
Journal: Journal of molecular and cellular cardiology
Published: August 27, 2021
Metabolically stable apelin-analogues, incorporating cyclohexylalanine and homoarginine, as potent apelin receptor activators.
Journal: RSC medicinal chemistry
Published: April 06, 2021
Optimizing PEG-Extended Apelin Analogues as Cardioprotective Drug Leads: Importance of the KFRR Motif and Aromatic Head Group for Improved Physiological Activity.
Journal: Journal of medicinal chemistry
Published: October 01, 2020
Interaction between the apelinergic system and ACE2 in the cardiovascular system: therapeutic implications.
Journal: Clinical science (London, England : 1979)
Published: July 21, 2020
ACE2 (Angiotensin-Converting Enzyme 2)-Mediated Protection From Pulmonary Hypertension: Lung-Gut Axis at Center Stage.
Journal: Hypertension (Dallas, Tex. : 1979)
Published: June 11, 2020
Last Updated: 09/26/2026